Home » ZELTIA TO INVEST 155 MLN EUROS IN DRUG UNITS
ZELTIA TO INVEST 155 MLN EUROS IN DRUG UNITS
August 5, 2005
Spanish chemicals and biotech company Zeltia (ZEL.MC: Quote, Profile, Research) said on Thursday it will invest 155 million euros ($190.9 million) until 2007 in its fledgling pharmaceutical units PharmaMar and Neuropharma. The money will come from capital increases already completed, the sale of non-strategic assets and from Zeltia's chemical subsidiaries. Zeltia's marine biotech unit PharmaMar will receive 114.3 million euros and the rest will go to Neuropharma.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct